Ambry researchers recently published a study suggesting that roughly 40 percent of genetic variants reported in raw data from DTC genetic tests may be wrong.
The company shared details of its methods and results of some internal experiments but has been met with skepticism by members of the research community.
Gencove, a New York Genome Center spinout, will provide its low-pass sequencing solution to Onegevity's multi-omic artificial intelligence platform and services.
Fox10 in Phoenix reports on a Facebook-based support group for people who learn through direct-to-consumer genetic testing that a parent isn't a biological parent.
The Oregon state Senate unanimously passed a bill that would make it easier for people convicted of crimes to initiate DNA testing of evidence, according to the Associated Press.
Florida state senators are to weigh a bill prohibiting life insurance companies from using genetic information in coverage decisions, according to Florida Politics.
In Genome Research this week: metagenomic sequencing assay that detects pathogens in cerebrospinal fluid, single-tube long fragment read approach, and more.
